He has been criticized for the fact that the research was funded by Synthetic Genomics, a company that he cofounded, which will hold the intellectual property rights resulting from the research – and has already filed for 13 patents related to it. But the work has taken 20 scientists a decade to complete, at an estimated cost of $40 million, and commercial investors are an obvious source for such funds.